Estradiol dienanthate
From Wikipedia, the free encyclopedia
 |
|
| Clinical data | |
|---|---|
| Routes of administration |
Intramuscular injection |
| Identifiers | |
|
Systematic (IUPAC) name: (3-heptanoyloxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl) heptanoate
|
|
| Synonyms | Estradiol dienantate |
| CAS Number | 7732-97-0 |
| PubChem (CID) | 24420 |
| ChemSpider | 145199 |
| UNII | 65C72P1860 |
| Chemical and physical data | |
| Formula | C32H48O4 |
| Molar mass | 496.72112 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
Estradiol dienanthate, or estradiol 3,17-dihepanoate, is a semisynthetic, steroidal estrogen.[1] It is an estrogen ester, specifically, and an ester of estradiol.[1] The drug is a component of Climacteron, an injectable combination formulation of testosterone enanthate, estradiol dienanthate, and estradiol benzoate that is used in the treatment of menopausal symptoms in women.[2][3][4]
See also[edit]
References[edit]
- ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 898. ISBN 978-1-4757-2085-3.
- ^ Ginsburg, Elizabeth S. (1999). "Androgen Replacement in Postmenopausal Women". 18: 209–219. doi:10.1007/978-1-59259-246-3_13.
- ^ Robert B. Greenblatt; William E. Barfield; Edwin C. Jungck (January 1962). "The treatment of the menopause". Can Med Assoc J. 86 (3): 113–4. PMC 1848811
. PMID 13901504. - ^ David B. Seifer (27 July 1999). Menopause: Endocrinology and Management. Springer Science & Business Media. pp. 183–. doi:10.1007/978-1-59259-246-3. ISBN 978-1-59259-246-3.
 |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 |
This article about a steroid is a stub. You can help Wikipedia by expanding it. |
